Showing results (191-200 of 3,454) with videos related to
Sort By:
Pageof 346
Expert Opinion on Biological Therapy|November 10, 2015
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational dataElena Nikiphorou, Hannu Kautiainen, Pekka Hannonen, et al.Expert Opinion on Biological Therapy|March 25, 2016
Considerations for the combination of anticancer vaccines and immune checkpoint inhibitorsJulius Strauss, Ravi A Madan, James L GulleyExpert Opinion on Biological Therapy|April 13, 2016
Reprogramming cancer cells: overview & current progressKian Lam Lim, Hoon Koon Teoh, Pei Feng Choong, et al.Expert Opinion on Biological Therapy|May 7, 2019
An update on gene therapy for lysosomal storage disordersMurtaza S Nagree, Simone Scalia, William M McKillop, et al.Expert Opinion on Biological Therapy|May 30, 2019
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world studyMatteo Megna, Luisa Di Costanzo, Giuseppe Argenziano, et al.Expert Opinion on Biological Therapy|August 1, 2018
Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domainRuchi Shah, Karina Reyes-Gordillo, Marcos RojkindExpert Opinion on Biological Therapy|August 1, 2018
Thymosin beta 4 and the eye: the journey from bench to bedsideGabriel SosneExpert Opinion on Biological Therapy|August 1, 2018
Thymosin β4-mediated protective effects in the heartRabea Hinkel, Katharina Klett, Andrea Bähr, et al.Expert Opinion on Biological Therapy|August 1, 2018
Serum thymosin alpha 1 levels in normal and pathological conditionsFrancesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, et al.Expert Opinion on Biological Therapy|April 9, 2019
IL-17 inhibition in axial spondyloarthritis: current and future perspectivesMurat Torgutalp, Denis PoddubnyyPageof 346